Opinions & Features

On June 15, Medtronic, Inc. announced its proposed acquisition of Covidien plc for $42.9 billion in cash and stock.

Business is war and nothing is more illustrative of that point than a healthy cycle of M&A activity.

Yesterday in a move that returned attention to healthcare takeovers, Bill Ackman, CEO of the hedge fund Pershing Square Capital, announced a bold and unusual move by partnering with pharmaceutical company, Valeant Pharmaceuticals International, Inc.[...]

For today, the buzz surrounding Carl Icahn derives from his initiative to separate PayPal from eBay. More frequently, people tend to equate Icahn with his investment strategy; including his activism in Apple and significant[...]

What is the single most important, immediate technological innovation in healthcare today? Many would respond that stem cells, gene therapy, or biologics are the most important innovations. Yes, they are critical, but think differently.

I am often asked to comment on a range of medical treatments – from new drugs to medical devices and procedures. Investors will inquire about a new treatment or procedure to gauge the likelihood[...]

The U.S. is now in the grip of a nationwide influenza surge that threatens the lives of thousands of people. City and state governments are declaring health emergencies and television personalities are getting vaccinated on[...]

Early in March 2012, 77-year-old Richard Poling entered a clinic in Bonita Springs, Florida for a stem cell treatment to help with age related heart and lung conditions. Mr. Poling, an avid golfer and[...]

Imagine that an infectious disease of uncertain cause strikes a few residents of a small town after a woman returns from a trip overseas. Within days the disease has spread to major cities; within weeks[...]